NDC 51311-034 - AYRADIA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51311-034
- Package NDCs from labels
- 51311-034-30, 51311-034-10
- Manufacturer
- Virbac AH Inc
- Effective date
- 2023-10-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| AYRADIA - Virbac AH Inc | Virbac AH Inc | 2023-10-26 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51311-034-10 | AYRADIA | 100 mL in 1 BOTTLE | SOLUTION | 100 | 1 | |
| 51311-034-10 | AYRADIA | 1 in 1 CARTON | SOLUTION | 1 | 1 | |
| 51311-034-30 | AYRADIA | 1 in 1 CARTON | SOLUTION | 1 | 1 | |
| 51311-034-30 | AYRADIA | 30 mL in 1 BOTTLE | SOLUTION | 30 | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metronidazole | METRONIDAZOLE | BluePoint Laboratories | 3cf021b6-5794-4a86-b09d-bece0ba8b302 | 2026-02-23 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Viona Pharmaceuticals Inc | 40a8c59b-a46d-4e5b-bd38-330cdbc1022c | 2026-02-19 | Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Zydus Lifesciences Limited | aa7fc40e-64a1-4155-bb39-77ed7b7f2e67 | 2026-02-19 | 140QMO216E | |
| metronidazole vaginal | METRONIDAZOLE | REMEDYREPACK INC. | b8fbd105-90ae-4af4-9313-61834aaf4a2c | 2026-02-13 | Warnings, Adverse reactions | 140QMO216E |
| metronidazole vaginal | METRONIDAZOLE | REMEDYREPACK INC. | b07f42dd-75d4-499a-984f-c06894ff3a45 | 2026-02-12 | Warnings, Adverse reactions | 140QMO216E |
| metronidazole | METRONIDAZOLE | Sportpharm LLC | dc8e448e-ac4e-4efc-8851-c368e31b9d69 | 2026-02-05 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Fougera Pharmaceuticals, LLC | 43ed872b-63ac-4a22-9c9e-cc0e05bcc41e | 2026-01-28 | Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Fougera Pharmaceuticals, LLC | 5368755a-dd37-4e34-843f-ece6bac8ef6a | 2026-01-28 | Adverse reactions | 140QMO216E |
| Firming antibacterial | FIRMING ANTIBACTERIAL | Jiangxi He-Oumei Health Industry Co., Ltd. | 4923cdbf-a3a3-02f4-e063-6394a90ab889 | 2026-01-24 | Warnings | 140QMO216E |
| Metronidazole | METRONIDAZOLE | REMEDYREPACK INC. | 1a28dce0-07af-401a-a6ac-1c2ee559c668 | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| PYLERA | BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE | H2-Pharma, LLC | c50626a2-5969-490b-a88a-a4ee45e79615 | 2026-01-16 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| metronidazole | METRONIDAZOLE | Preferred Pharmaceuticals Inc. | ab695a3e-1721-491a-97a2-c3f617a8d9fc | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | GLENMARK PHARMACEUTICALS INC., USA | 6736c100-a7fe-44ea-8579-5537537ff9b8 | 2026-01-09 | Warnings, Adverse reactions | 140QMO216E |
| METRONIDAZOLE | METRONIDAZOLE | Direct_Rx | 90a5acb3-f8cc-1e82-e053-2995a90a4e97 | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | American Health Packaging | c90da73c-e48e-411a-bd75-0b107f1141cc | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Solaris Pharma Corporation | 94a83daa-6e34-419d-849a-6f18d3b8c586 | 2026-01-07 | Warnings, Adverse reactions | 140QMO216E |
| metronidazole | METRONIDAZOLE | Northwind Health Company, LLC | 06bd4afb-4a45-294c-e063-6394a90a7ab1 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Northwind Health Company, LLC | f2f55405-7f21-3ccc-e053-2a95a90a195a | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Northwind Health Company, LLC | f7e5dacd-0bc4-4ac4-e053-6394a90a457a | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Proficient Rx LP | a56c2842-8ad4-4396-8eb6-cbcd1629fcb1 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.